AVROBIO, Inc. (AVRO) financial statements (2020 and earlier)

Company profile

Business Address ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments187126
Cash and cash equivalents187126
Receivables00
Prepaid expense10
Other current assets11
Other undisclosed current assets72
Total current assets:196130
Noncurrent Assets
Property, plant and equipment43
Other noncurrent assets11
Total noncurrent assets:53
TOTAL ASSETS:201133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1411
Accounts payable43
Accrued liabilities108
Total current liabilities:1411
Noncurrent Liabilities
Liabilities, other than long-term debt01
Deferred rent credit01
Total noncurrent liabilities:01
Total liabilities:1511
Stockholders' equity
Stockholders' equity attributable to parent186122
Common stock00
Additional paid in capital331194
Accumulated deficit(145)(72)
Total stockholders' equity:186122
TOTAL LIABILITIES AND EQUITY:201133

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(76)(46)
Operating loss:(76)(46)
Nonoperating income (expense)3(0)
Investment income, nonoperating30
Other nonoperating expense(0)(0)
Net loss attributable to parent:(73)(46)
Preferred stock dividends and other adjustments (2)
Net loss available to common stockholders, diluted:(73)(49)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(73)(46)
Comprehensive loss, net of tax, attributable to parent:(73)(46)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: